メニュー
DIA 2017 is located at:
McCormick Place
Gate 4
2301 South Martin Luther King Jr. Drive
Chicago, IL
Go
Gate 4
2301 South Martin Luther King Jr. Drive
Chicago, IL
プログラム委員会
-
Teresa Ancukiewicz, MA • Associate Director
Boston Scientific Corporation, United States -
Kimberly Belsky, MS • Reg Policy & Intell and AdPromo, Regulatory Affairs
Independent, United States -
Larry Blankstein, PhD • Head of Clinical Operations
Synlogic, United States -
Daniel Bollag, PhD • Chief Strategy Officer
Ocular Therapeutics, United States -
Linda Bowen, MSc, RAC • Assistant Adjunct Temple University
Temple University Pharmacy School, United States -
Bill Byrom, PhD • Vice President, Product Intelligence and Positioning; Principal, eCOA Science
Signant Health , United Kingdom -
Joy A. Cavagnaro, PhD • President
Access BIO, United States -
Dannis Chang, PharmD • Director, Hematology Medical Information Team Lead
Genentech, Inc., United States -
Karla Childers, MS • Head, Bioethics-Based Science and Technology Policy
Johnson & Johnson, United States -
Leah Christl, PhD • Exec Director, Global Biosimilars Regulatory Affairs & Regulatory & R&D Policy
Amgen, United States -
Brenda Crowe, PhD • Associate Vice President, Statistics
Eli Lilly and Company, United States -
Sara Doshi, PharmD • Senior Director, Decentralized Clinical Trials
Eli Lilly and Company, United States -
Betsy Fallen, RN • Consultant
BAFallen Consulting LLC, United States -
Barbara Gladson, PhD, MS • Director of Biopharma Initiative; Interim Chair, Health Informatics
Rutgers School of Health Professions, United States -
Richard Gliklich, MD • Chief Executive Officer
OM1, United States -
Jonathan Haddad, MPH • HIV Disease Area Head, Clinical Statistics
GlaxoSmithKline, United States -
Martin Harvey Allchurch, LLM • Head of International Affairs
European Medicines Agency, Netherlands -
Jonathan Solomon Helfgott, MS • Senior Lecturer, Faculty, & Program Coordinator,
Johns Hopkins University, United States -
Frank Hubbard, PhD, MS • President
Global Regulatory Writing Solutions Inc., United States -
Ginny Hussong • Branch Chief, Data Standards, CBER
FDA, United States -
Nita Ichhpurani, PMP • Consultant To Daiichi Sankyo, Inc.
Phase One Forward, Consultant, Canada -
John Kamp • Washington Counsel
Coalition For Healthcare Communication (CHC), United States -
Sean Kassim, PhD • Director, Office of Study Integrity and Surveillance, OTS, CDER
FDA, United States -
Ellen Kelso • Head, Knowledge Strategy
KSE Ltd., United States -
Lynn King, MHA • Chief Operating Officer
M3 Wake Research, Inc, United States -
Agnes Klein, MD • Senior Medical Advisor
Health Canada, Canada -
Stephen Knowles, MD, MRCP • Chief Medical Officer
Halozyme Therapeutics, United States -
Mark Kryah, PMP • Executive Director, Program Team Leader, Program and Portfolio Management
Ultragenyx Pharmaceutical Inc., United States -
Andrea C. Masciale, JD • Vice President, Regulatory Policy and Global Analytics
Johnson & Johnson, United States -
Ann Meeker-O'Connell, MS • Director, Office of Clinical Policy, Office of Clinical Policy and Programs, OC
FDA, United States -
Mary Murray, MBA, MS • Family Caregiver
Independent Consultant, United States -
Bob Muzerall • Vice President, Sales & Sales Training
AMPLEXOR Life Sciences, LLC, United States -
Jane Elizabeth Myles, MSc • Program Director
Decentralized Trials and Research Alliance, United States -
Roger Nosal, PhD • Vice President, Head of Global CMC
Pfizer Inc, United States -
Lisa Palladino-Kim, MS • Program Director / Lecturer
Rutgers School of Health Professions Clin Research Mgmt, United States -
Christine Pierre, RN • President
Society for Clinical Research Sites, United States -
Sarah Pope Miksinski, PhD • Executive Director, CMC Regulatory Affairs
Gilead Sciences, United States -
Kim Quaintance-Lunn • Vice President, Head of Regulatory Science and Execution
Alexion, United States -
Badri Rengarajan, MD • Life Sciences
Jazz Pharmaceuticals, United States -
Margaret Richards, PhD, MPH • Executive Director, Solutions
Panalgo, United States -
Mitra Rocca, MSc • Associate Director, Medical Informatics, Office of Translational Science, CDER
FDA, United States -
Matthew D. Rotelli, PhD, MS • Vice President, Bioethics
Eli Lilly and Company, United States -
Leslie Sam • President
Leslie Sam and Associates, LLC, United States -
David H. Schubert •
DH Schubert Regulatory Solutions LLC, United States -
Leigh Shultz, PhD, PMP • Executive Director, Human Health Commercial Operations
Merck & Co., Inc., United States -
Ashley F. Slagle, PhD, MS • Principal, Scientific and Regulatory Consulting
Aspen Consulting, LLC, United States -
Nancy Pire Smerkanich, DrSc, MS • Assistant Professor Regulatory & Quality Sciences
University of Southern California School of Pharmacy, United States -
William B. Smith, MD • CEO
Alliance for Multispecialty Research, LLC , United States -
Elizabeth Somers, MS • Executive Director, Global Project and Alliance Management
Merck Sharp & Dohme LLC, United States -
Jeffrey N. Stuart, PhD • Associate Vice President, Global Regulatory Affairs
Merck Sharp & Dohme LLC , United States -
Ling Su, PhD • Research Fellow
Shenyang Pharmaceutical University, Yeehong Business School, China -
Toshiyoshi Tominaga, PhD • Project Professor
Keio University Hospital, Japan -
Annette S. Williams, MBA, RPh • Vice President, Pharmacovigilance
IQVIA, United States